top of page

We are pleased to announce that icometrix is now a GE HealthCare company. Click here to learn more.

Amyloid-related imagign abnormalities.png

Parkinson’s disease 

Quantifies volumes of basal ganglia, brainstem, cerebellum, cortex, and ventricles.

icobrain pd

icobrain pd (only available for research) enables volumetric assessment of the basal ganglia, brainstem and cerebellum, cortical lobes, and ventricles, as well as measures of whole brain volume.

​

Key scientific publications

A deep learning model for brain segmentation across pediatric and adult populations

Simarro et al. (2024)

Health Economic Impact of Software-Assisted Brain MRI on Therapeutic Decision-Making and Outcomes of Relapsing-Remitting Multiple Sclerosis Patients—A Microsimulation Study

Sima et al. (2021)

Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: validation of icobrain dm

Struyfs et al. (2020)

Whole brain and grey matter volume of Japanese patients with multiple sclerosis

Akaishi et al. (2017)

Intercontinental validation of brain volume measurements using MSmetrix

Finkelsztejn et al. (2017)

Reliable measurements of brain atrophy in individual patientswith multiple sclerosis

Smeets et al. (2016)

FOOTER IMAGE.webp

Make every clinical decision with confidence

Disease-specific solutions that impact outcomes

bottom of page